Humana (NYSE:HUM) Trading 2.7% Higher

Humana Inc. (NYSE:HUMGet Free Report)’s share price traded up 2.7% during trading on Tuesday . The company traded as high as $364.51 and last traded at $364.13. 220,050 shares changed hands during trading, a decline of 86% from the average session volume of 1,627,608 shares. The stock had previously closed at $354.47.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on HUM. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $395.00 price target on shares of Humana in a research report on Monday, August 19th. Oppenheimer lifted their price target on Humana from $370.00 to $400.00 and gave the company an “outperform” rating in a research note on Thursday, August 1st. JPMorgan Chase & Co. boosted their target price on Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 21st. Bank of America boosted their price target on Humana from $342.00 to $376.00 and gave the stock a “neutral” rating in a report on Monday, May 20th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on Humana from $341.00 to $349.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Thirteen research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $398.70.

Get Our Latest Stock Analysis on Humana

Humana Price Performance

The business’s 50 day moving average is $367.95 and its 200-day moving average is $347.21. The firm has a market capitalization of $43.96 billion, a P/E ratio of 22.44, a PEG ratio of 3.16 and a beta of 0.51. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.70.

Humana (NYSE:HUMGet Free Report) last issued its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.89 by $1.07. The company had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. Humana’s revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $8.94 earnings per share. As a group, sell-side analysts predict that Humana Inc. will post 16.14 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 0.97%. The ex-dividend date is Monday, September 30th. Humana’s payout ratio is presently 22.04%.

Institutional Trading of Humana

A number of institutional investors have recently modified their holdings of the business. Benjamin F. Edwards & Company Inc. grew its holdings in Humana by 14.8% in the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 490 shares of the insurance provider’s stock worth $225,000 after acquiring an additional 63 shares during the last quarter. Private Advisor Group LLC grew its position in Humana by 15.0% during the fourth quarter. Private Advisor Group LLC now owns 3,339 shares of the insurance provider’s stock valued at $1,529,000 after buying an additional 436 shares during the period. Apollon Wealth Management LLC lifted its holdings in Humana by 3.9% during the fourth quarter. Apollon Wealth Management LLC now owns 3,142 shares of the insurance provider’s stock valued at $1,438,000 after purchasing an additional 118 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in Humana by 3.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 818,040 shares of the insurance provider’s stock valued at $374,507,000 after purchasing an additional 26,879 shares in the last quarter. Finally, National Pension Service lifted its holdings in Humana by 3.0% during the fourth quarter. National Pension Service now owns 291,916 shares of the insurance provider’s stock valued at $133,642,000 after purchasing an additional 8,546 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

About Humana

(Get Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

See Also

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.